ESR1 and breast cancer: As shown in Fig 4D and 4E, the target-specific staining of the nuclei of ERα-positive MCF-7, which is comparably non-specific and less intense in the ERα-deficient MDA-MB-231 cells, suggest the specific binding of ERaptD4 to its target protein in ERα-positive breast cancer cells.